Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

5/2/2018, Wednesday

Media Contacts:
Kristy Marks
(908) 927-0683 

Don Murphy
(212) 299-8970


BRIDGEWATER, N.J., May 2, 2018 – Bausch + Lomb, a leading global eye health company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Bausch + Lomb ULTRA® family of contact lenses for extended wear for up to seven days between removals for cleaning and disinfection or disposal of the lens, as recommended by the eye care professional. First introduced in the United States in 2014, Bausch + Lomb ULTRA is the only brand of contact lenses that include MoistureSeal® technology, a patented combination of material and manufacturing process, which helps to maintain 95 percent of lens moisture for a full 16 hours.1

“We are proud of today’s regulatory milestone, which signifies that Bausch + Lomb ULTRA contact lenses provide additional options for eye care professionals to help meet the lifestyle demands and preferences of their patients,” said John Ferris, general manager, U.S. Vision Care, Bausch + Lomb. “With this latest indication for Bausch + Lomb ULTRA, we continue to deliver on our promise to provide a wide range of innovative solutions that help address the evolving needs of patients and eye care professionals alike.”

Bausch + Lomb ULTRA contact lenses are engineered to provide all-day comfort and consistently clear vision. The family of contact lenses features polyvinylpyrrolidone (PVP) for enhanced wettability, a high Dk/t (163) and low modulus (70). The Bausch + Lomb ULTRA family of contact lenses are also available for patients with astigmatism and presbyopia, and are among the fastest growing families of contact lenses.2

“Bausch + Lomb ULTRA contact lenses are a trusted and preferred lens option for my practice and my patients,” said Ben Gaddie, O.D., Gaddie Eye Centers, Louisville, KY. “Now with the extended wear indication, I can offer these lenses to patients who prefer a longer wearing schedule as part of their lifestyle.” 

For more information, visit

Important Safety Information about Bausch + Lomb ULTRA Contact Lenses (Extended Wear)
The risk of microbial keratitis and other potentially vision-threatening adverse events has been shown to be greater among users of extended wear contact lenses than among users of daily wear contact lenses. If a patient experiences eye discomfort, excessive tearing, vision changes, or redness of the eye, the patient should be instructed to immediately remove the lenses and promptly contact his or her eye care practitioner.

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Our core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.


  1. Data on file. Bausch & Lomb Incorporated. Rochester, NY; 2013.
  2. Lens sales between January 2016-October 2017 among silicon hydrogel planned replacement contact lenses.


Bausch + Lomb ULTRA and MoistureSeal are trademarks of Bausch & Lomb Incorporated or its affiliates.
All other trademarks are the property of their respective owners.  
© 2018 Bausch & Lomb Incorporated.


Number of views (2239)/Comments (0)